Diane Gordon, M.D., is Assistant Professor of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Diane Gordon, M.D., is Assistant Professor of Anesthesia, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio.

Close modal

Sean Michael McGarry, M.D., is Attending Anesthesiologist, Oregon Anesthesia Group, Good Samaritan Regional Medical Center, Corvallis, Oregon.

Sean Michael McGarry, M.D., is Attending Anesthesiologist, Oregon Anesthesia Group, Good Samaritan Regional Medical Center, Corvallis, Oregon.

Close modal

Environmental contamination by pharmaceuticals is well-documented worldwide.  The environmental burden of apharmaceutical generally correlates with the amount that isdispensed, and therefore the most commonly utilized medications (birth control, antihypertensives, antibiotics, antiepileptics, mood stabilizers and over-the-counter analgesics) are those most frequently found in the environment.3  Propofol is the medication most frequently wasted in the O.R. by volume,7  and although it is not currently regulated by the Drug Enforcement Administration (DEA), it was recommended by the DEA in 2010 to be added as a schedule IV drug like fospropofol.8  Propofol has been treated as a controlled substance in Alabama, Georgia and North Dakota as well as by certain health care systems. Midazolam, acetaminophen-codeine and fentanyl contributed nearly 90 percent by weight to the total controlled drug waste from two hospitals in one study.9  Proper disposal of controlled substances, including propofol, would prevent both environmental contamination as well as unlawful diversion.

What exactly constitutes “proper disposal”? Federal, state and local governmental entities, as well as non-governmental public interests and facilities themselves, have rules or recommendations that enter into the discussion, so there is no “one size fits all” answer. There are regulations from a veritable alphabet soup of agencies, including the DEA, Environmental Protection Agency (EPA), Department of Transportation (DOT), Occupational Safety and Health Administration (OSHA), state EPAs, state pharmacy boards, and local publicly owned treatment works (POTW, i.e., wastewater treatment plants). The EPA classifications, under the Resource Conservation and Recovery Act (RCRA), are the most widely known and include “hazardous substances” (U-list) and “acutely hazardous” (P-list).10  Of note, these lists have not been updated in many years. In addition to the P and U lists, drugs may exhibit a characteristic of hazardous waste, such as ignitability or toxicity, based on their specific formulations; however, these drugs are generally not used in anesthesia. Since no drugs should be disposed down the drain without the specific permission of the local POTW, some health care facilities have provided containers for disposal of either hazardous or non-hazardous pharmaceutical waste in the O.R. setting, although this is not always the case. Anesthesia medications, including controlled substances, are often referred to as “non-P/non-U listed” and do not carry regulatory obligations for hazardous waste disposal. Regulations from the DEA focus solely on potential of diversion, mandating that controlled substances be “non-retrievable” or unable to be recovered for use/abuse. In contrast to unused expired medications, which must be disposed of by the pharmacy via a reverse distributor, medications charged out to a patient are required only to be managed in such a way as to prevent diversion.11  States, health systems or individual hospitals therefore have created their own policies for wasting controlled substances and non-controlled substances from the O.R. Historically, controlled substances have been wasted down the drain, witnessed, in order to comply with the DEA’s diversion requirements. This practice directly contaminates the environment, as wastewater treatment plants are not designed to remove medications or their potentially harmful degradation products.12,13 

An alternative to disposal of controlled drugs into the sink is use of a medication disposal system, which is a receptacle for pharmaceuticals that uses either a binding agent or denaturing agent that solidifies liquids to render them unrecognizable and unrecoverable. Examples of approved systems include Stryker’s Cactus Smart Sink® and Pharma Lock® O.R., and Rx Destroyer™. The contents of these containers should then be disposed through incineration unless specifically permitted into the local landfill. However, termination of the solidified drug into landfills ultimately leads to contamination of groundwater due to leaching into the environment.2 

Stryker’s Cactus Smart Sink® and Pharma Lock® O.R. Controlled Substances Waste Management Systems. Photo courtesy of Stryker Corporation.

Stryker’s Cactus Smart Sink® and Pharma Lock® O.R. Controlled Substances Waste Management Systems. Photo courtesy of Stryker Corporation.

Close modal

Guidance from a drug’s manufacturer could be helpful in determining its ecotoxicity and best disposal practices. However, the safety data sheets (SDSs) in the U.S. don’t include details of ecotoxicity, and the section of the SDS titled “Disposal Considerations” is frequently nonspecific, suggesting only to follow federal, state and local regulations.14,15  European SDSs disclose far more information, even stating that a medication should not be disposed of down the drain16  or that incineration is recommended for destruction.17 

Virtually all medications drawn up from vials will end up in the environment in some form. Direct disposal into wastewater is least preferable, but disposal into landfilled trash only delays the inevitable migration of the pharmaceutical into groundwater. Toxic byproducts of incineration have been identified, particularly when plastic is combusted; however, incineration in an approved facility is the only method that will prevent the majority of aquatic pollution due to pharmaceutical waste disposal. All incinerators must meet appropriate Maximum Achievable Control Technology standards, which reduces the emissions released during incineration.18 

In anesthesia practice, propofol is the most wasted medication by volume, while emergency drugs (succinylcholine, atropine, epinephrine, ephedrine) have the highest waste fractions (percent of opened drug that is not used and must be wasted).7  Though the full environmental impact of these medications is not known, there is legitimate concern for the bioaccumulation of propofol. It is not biodegradable in water or anaerobic conditions, and incineration is required for its destruction.7 

Ecotoxicity literature on pharmaceuticals is both substantial and insufficient. Propofol and morphine are considered toxic to aquatic life (the established surrogate marker of ecotoxicity).5  Of all the controlled substances commonly used in anesthesia, morphine has the most established experimental ecotoxicity data.6  Diazepam, the most studied of the benzodiazepines, has been found in surface and groundwater worldwide19  and is resistant to degradation in the environment. Low levels have been shown to affect aquatic species’ behavior,19,20  and there is growing concern for the effects of chronic low-level exposure on ecosystems and on humans. Ketamine is not susceptible to microbial degradation or hydrolysis, and its phototransformation results in byproducts that are similar to human metabolites, demonstrating that analysis of metabolites in the environment is even more lacking than analysis of the parent pharmaceuticals themselves.21 

Chloral hydrate, a class IV controlled substance used for sedation primarily in pediatric anesthesia, is a U-list medication and must be disposed of into the appropriate receptacle as it is regulated by the EPA. Physostigmine salicylate (though not a controlled substance and whose use in anesthesia is only for diagnosis and treatment of central anticholinergic syndrome) is worth mentioning because it is P-listed. For all medications not regulated by the EPA, the DEA edict of “non-divertible” is the main federal guidance that applies to clinicians. For this reason, the sink or trash has historically been the preferred route of disposal for clinicians due to simplicity.

One alternative to sink or “regular” trash disposal is the sharps container. While the sharps container is theoretically a “non-divertible” location, there are numerous examples to prove otherwise.22  A fatality was recently described when a narcotic-dependent woman drained out the liquid from a sharps container in her employer’s emergency department and injected the contents. This liquid contained not only narcotics but also rocuronium.23  Sharps containers are not designed to sequester wasted controlled substances and should not be used for this purpose due to risk of diversion as well as the possibility of environmental contamination if the sharps container is landfilled rather than incinerated.

“Virtually all medications drawn up from vials will end up in the environment in some form. Direct disposal into wastewater is least preferable, but disposal into landfilled trash only delays the inevitable migration of the pharmaceutical into groundwater.”

The recent introduction of the medication disposal systems previously discussed are likely the best means for disposal of controlled substances currently available as they render the medications unusable, provided the medications are ultimately incinerated. Unfortunately, their cost can be significant, and the motivation of a health care facility to change to a new disposal practice can be low. Despite these challenges, such systems are rapidly gaining in popularity, especially as medication waste practices are receiving greater scrutiny from The Joint Commission and their accreditation alternatives, such as DNV GL.

All unused prepared medications that leave their vials will end up in the environment in some form. These medi-cations must be disposed of, and therefore judicious use will decrease environmental contamination. Propofol waste was significantly reduced at Cincinnati Children’s Hospital by using the chart in Table 1 for propofol infusions. Additionally, avoidance of unnecessarily large vials of medi-cation decreases the waste fraction.7  Pre-filled syringes of small quantities of fentanyl decreased the waste fraction at a pediatric institution.24  Generally, outsourced pre-filled syringes have a relatively long shelf life and can be re-stocked if not opened, reducing waste.25 

The list of “hazardous waste drugs” that fall under EPA jurisdiction should be updated to reflect controlled substances and propofol. Finally, federal and state laws should be brought into alignment to reduce confusion for policymakers.

A comprehensive plan to reduce the environmental burden of pharmaceuticals must include proper disposal. Disposal into sinks, toilets and trash must be discouraged, while incentivizing proper disposal by incineration. Commercial medication disposal systems, like those mentioned earlier, are a new, industry-borne solution for simplicity, compliance, diversion avoidance and environmental protection.

Among the many responsibilities of the anesthesia provider, attention to the environmental impact of our practice must not be forgotten. Controlled substances, like other anesthetic medications, will contaminate the environment if not properly destroyed by incineration. Drug waste can be minimized through careful planning of case requirements and through reliance on pre-filled syringes. Reduction of the amounts of unused drugs coupled with proper disposal will minimize water contamination for future generations. Pharmaceuticals are nearly ubiquitous in freshwater world-wide, and we all (quite literally) live downstream. O.R. pharmaceuticals are one piece of a large puzzle, but it is a piece that all anesthesia providers handle every day.

The authors would like to thank Charlotte A. Smith, R.Ph., M.S., Kathleen A. Skibinski, R.Ph., M.S., Monica Livingston and Russell F. Mankes, Ph.D., for their expertise and assistance with this manuscript.

1.
World Health Organization
.
Pharmaceuticals in drinking water
. http://www.who.int/water_sanitation_health/publications/2011/pharmaceuticals_20110601.pdf.
Published 2011. Last accessed February 8, 2018
.
2.
Kümmerer
K
.
Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review
.
Chemosphere
.
2001
;
45
(
6-7
):
957
969
.
3.
Corcoran
J
,
Winter
MJ
,
Tyler
CR
.
Pharmaceuticals in the aquatic environment: a critical review of the evidence for health effects in fish
.
Crit Rev Toxicol
.
2010
;
40
(
4
):
287
304
.
4.
Rivera-Utrilla
J
,
Sánchez-Polo
M
,
Ferro-García
,
Prados-Joya
G
,
Ocampo-Pérez
R
.
Pharmaceuticals as emerging contaminants and their removal from water. A review
.
Chemosphere
.
2013
;
93
(
7
):
1268
1287
.
5.
Frédéric
O
,
Yves
P
.
Pharmaceuticals in hospital wastewater: their ecotoxicity and contribution to the environmental hazard of the effluent
.
Chemosphere
.
2014
;
115
:
31
39
.
6.
Orias
F
,
Perrodin
Y
.
Characterisation of the ecotoxicity of hospital effluents: a review
.
Sci Total Environ
.
2013
;
454-455
:
250
276
.
7.
Mankes
RF
.
Propofol wastage in anesthesia
.
Anesth Analg
.
2012
;
114
(
5
):
1091
1092
.
8.
US Drug Enforcement Administration
.
Schedules of controlled substances: placement of propofol info Schedule IV; proposed rule
.
Fed Regist
.
2010
;
75
(
207
):
66196
66199
.
Codified at 21 CFR Part 1208. https://www.gpo.gov/fdsys/pkg/FR-2010-10-27/pdf/2010-27193.pdf. Last accessed February 9, 2018
.
9.
Mankes
RF
,
Silver
CD
.
Quantitative study of controlled substance bedside wasting, disposal and evaluation of potential ecologic effects
.
Sci Total Environ
.
2013
;
444
:
298
310
.
10.
Practice Greenhealth
.
Managing pharmaceutical waste: a 10-step blueprint for healthcare facilities in the United States
. https://practicegreenhealth.org/sites/default/files/upload-files/pharmwasteblueprint.pdf.
Revised August 2008. Last accessed February 9, 2018
.
11.
Letter to Registrants seeks to clarify the DEA position regarding a practitioner’s disposal of pharmaceutical wastage
.
US Depart-ment of Justice Drug Enforcement Administration website
. https://www.deadiversion.usdoj.gov/drug_disposal/dear_practitioner_pharm_waste_101714.pdf.
Published October 17, 2014. Last accessed February 9, 2018
.
12.
Kostich
MS
,
Batt
AL
,
Lazorchak
JM
.
Concentrations of prioritized pharmaceuticals in effluents from 50 large wastewater treatment plants in the US and implications for risk estimation
.
Environ Pollut
.
2014
;
184
:
354
359
.
13.
Huerta-Fontela
M
,
Galceran
MT
,
Ventura
F
.
Occurrence and removal of pharmaceuticals and hormones through drinking water treatment
.
Water Res.
2011
;
45
(
3
):
1432
1442
.
14.
Propofol safety data sheet
.
Msds Catalog Services LLC website
. https://www.msdsdigital.com/propofol-injectable-emulsion-1-msds.
Published February 18, 2017. Last accessed February 9, 2018
.
15.
Fentanyl safety data sheet
.
Msds Catalog Services LLC website
. https://www.msdsdigital.com/fentanyl-msds.
Published April 13, 2016. Last accessed February 9, 2018
.
16.
Propofol safety data sheet
.
British Pharmacopoeia website
. https://www.pharmacopoeia.com/Catalogue/Preview?uri=%2Fcontent%2Ffile%2Fproducts%2Fhealthandsafety%2FCat_1031_GB.pdf.
Published and revised July 9, 2013. Last accessed February 9, 2018
.
17.
Diprivan/propofol safety data sheet
.
AstraZeneca Australia website
. https://www.astrazeneca.com.au/content/dam/az-au/Material%20Safety%20Data/Diprivanltsupgt174ltsupgt.pdf.
Last revised March 23, 2012. Last accessed February 9, 2018
.
18.
Clean Air Act guidelines and standards for waste management
.
United States Environmental Protection Agency website
. https://www.epa.gov/stationary-sources-air-pollution/clean-air-act-guidelines-and-standards-waste-management.
Last accessed February 9, 2018
.
19.
Calisto
V
,
Esteves
VI
.
Psychiatric pharmaceuticals in the environment
.
Chemosphere
.
2009
;
77
(
10
):
1257
1274
.
20.
Huerta
B
,
Margiotta-Casaluci
L
,
Rodríguez-Mozaz
S
, et al
.
Anti-anxiety drugs and fish behavior: establishing the link between internal concentrations of oxazepam and behavioral effects
.
Environ Toxicol Chem.
2016
;
35
(
11
):
2782
2790
21.
Lin
AY
,
Lee
WN
,
Wang
XH
.
Ketamine and the metabolite norketamine: persistence and phototransformation toxicity in hospital wastewater and surface water
.
Water Res.
2014
;
53
:
351
360
.
22.
Berge
KH
,
Dillon
KR
,
Sikkink
KM
,
Taylor
TK
,
Lanier
WL
.
Diversion of drugs within health care facilities, a multiple-victim crime: patterns of diversion, scope, consequences, detection, and prevention
.
Mayo Clinic Proc.
2012
;
87
(
7
):
674
682
.
23.
Shaw
G
.
Proper drug disposal protects patients, caregivers
.
Anesthesiology News
. .
24.
Buck
D
,
Subramanyam
R
,
Varughese
A
.
A quality improvement project to reduce the intraoperative use of single-dose fentanyl vials across multiple patients in a pediatric institution
.
Pediatr Anesth
.
2016
;
26
(
1
):
92
101
.
25.
McCook
A
.
Prefilled syringes cut waste—and bottom line on drugs
.
Anesthesiology News
.
October 27, 2011
. https://www.anesthesiologynews.com/Policy-Management/Article/10-11/Prefilled-Syringes-Cut-Waste—and-Bottom-Line-on-Drugs/19192.
Last accessed February 9, 2018
.